LabCorp
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- $19.3B
- Website
- https://www.labcorp.com/
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
Completed
- Conditions
- Uterine CancerColorectal CancerPancreatic CancerMelanomaProstate CancerStomach CancerEsophageal CancerRhabdomyosarcomaLung CancerBreast Cancer
- Interventions
- Diagnostic Test: OmniSeq Test
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Labcorp Corporation of America Holdings, Inc
- Target Recruit Count
- 1429
- Registration Number
- NCT05697198
- Locations
- 🇺🇸
Clinical Site, Rock Hill, South Carolina, United States
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Not Applicable
Suspended
- Conditions
- Cancer DiagnosisBreast CancerMargins of ExcisionOncologyMargins, Tumor-Free
- Interventions
- Diagnostic Test: Zenith FLIM Diagnostics
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- Laser LabCorp
- Target Recruit Count
- 100
- Registration Number
- NCT04683120
- Locations
- 🇺🇸
Laser LabCorp, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath